“Experience in switching monoclonal antibodies in a patient with severe refractory atopic dermatitis: from Dupilumab to Abrocitinib. Case report ”, Rev Alerg Mex, vol. 72, no. 4, pp. 382–385, Dec. 2025, doi: 10.29262/ram.v72i4.1547.